measuregroup/AID255951

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103471040_AID255951_PMID16085413_VALUE7 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID160703992_AID255951_PMID16085413_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103471040_AID255951_PMID16085413_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103471039_AID255951_PMID16085413_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103471039_AID255951_PMID16085413_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103471040_AID255951_PMID16085413_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103471039_AID255951_PMID16085413_VALUE4
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/cell/CELLID179
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Inhibition concentration against C6 human breast cancer cells by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) method
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103471040 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103471039 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID160703992
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID255951

Total number of triples: 15.